Ethical Issues in Drug Testing, Approval and Pricing: The Clot-Dissolving Drugs

Perspectives in Biology and Medicine 40 (3):455 (1997)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Keywords

Reprint years

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,349

External links

  • This entry has no external links. Add one.
Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Ethical Issues in Drug Testing, Approval and Pricing: The Clot-Dissolving Drugs.Baruch A. Brody & Udo Schuklenk - 1998 - Bioethics 12 (1):79-81.
Ethical Issues in Drug Testing, Approval and Pricing: the Clot-Dissolving Drugs by Baruch A. Brody.U. Schueklenk - 1998 - Bioethics 12:79-81.
Ethical Issues in New Drug Prescribing.Lindsay W. Cole, Jennifer C. Kesselheim & Aaron S. Kesselheim - 2012 - Journal of Bioethical Inquiry 9 (1):77-83.
Delaying approval of a critical drug: Safety, efficacy, economics, compassion. [REVIEW]Leo T. Rosenberg - 1994 - Journal of Medical Humanities 15 (4):243-250.
Five Un‐Easy Pieces of Pharmaceutical Policy Reform.Marc A. Rodwin - 2013 - Journal of Law, Medicine and Ethics 41 (3):581-589.
The approval of over-the-counter HIV tests: Playing fair when making the rules. [REVIEW]Melissa Whellams - 2008 - Journal of Business Ethics 77 (1):5 - 15.
Judgments of the fairness of using performance enhancing drugs.John Sabini & John Monterosso - 2005 - Ethics and Behavior 15 (1):81 – 94.
Ethical considerations in the testing of biopharmaceuticals for adventitious agents.Richard S. Woodward - 1995 - Science and Engineering Ethics 1 (3):273-282.
Extraordinary Pricing of Orphan Drugs: Is it a Socially Responsible Strategy for the U.S. Pharmaceutical Industry? [REVIEW]Thomas A. Hemphill - 2010 - Journal of Business Ethics 94 (2):225 - 242.
Where Strategy and Ethics Converge: Pharmaceutical Industry Pricing Policy for Medicare Part D Beneficiaries.Edward R. Balotsky - 2009 - Journal of Business Ethics 84 (S1):75 - 88.
Pharmacogenetics: Ethical issues and policy options.Allen E. Buchanan, Andrea Califano, Jeffrey Kahn, Elizabeth McPherson, John A. Robertson & Baruch A. Brody - 2002 - Kennedy Institute of Ethics Journal 12 (1):1-15.
Drug testing and productivity.Nicholas J. Caste - 1992 - Journal of Business Ethics 11 (4):301 - 306.
America's Unjust Drug War.Michael Huemer - 2004 - In Bill Masters (ed.), The New Prohibition. Accurate Press.
A call to restructure the drug development process: Government over-regulation and non-innovative late stage (phase III) clinical trials are major obstacles to advances in health care.Thomas C. Jones - 2005 - Science and Engineering Ethics 11 (4):575-587.

Analytics

Added to PP
2014-03-25

Downloads
1 (#1,884,204)

6 months
1 (#1,533,009)

Historical graph of downloads

Sorry, there are not enough data points to plot this chart.
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references